Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1295
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01283048 | Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma | ||
| NCT01734915 | Detecting EGFR T790M Mutations From Circulating Tumor Cells | ||
| NCT06043674 | Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation | ||
| NCT02852655 | A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma | ||
| NCT04474626 | Isoquercetin in Sickle Cell Anemia | ||
| NCT01000155 | Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease | ||
| NCT04950608 | Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care | ||
| NCT04936243 | TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance) | ||
| NCT03408314 | The PediQUEST Response Intervention Study | ||
| NCT07052695 | Mosunetuzumab for CLL MRD Clearance | ||
| NCT00361244 | SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer | ||
| NCT02623972 | A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer | ||
| NCT04160065 | Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers | ||
| NCT01366092 | Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease | ||
| NCT00571298 | Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma | ||
| NCT05765500 | RecoverPC: Relugolix vs GnRH Agonist in Quality of Life | ||
| NCT03514433 | Translating Research Into Practice: Patient Navigation for Breast Cancer | ||
| NCT04620187 | Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas | ||
| NCT00588107 | A Web Site and Print Materials Intervention for Smoking Intervention for Childhood and Young Adult Cancer Survivors | ||
| NCT00458536 | Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF | ||
| NCT06366347 | ALPINE: Maintenance Letrozole/Abemaciclib | ||
| NCT01560416 | Fulvestrant With or Without Ganetespib in HR+ Breast Cancer | ||
| NCT00455897 | CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma | ||
| NCT01754389 | Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant | ||
| NCT00790010 | Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma | ||
| NCT00165516 | Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate | ||
| NCT01516216 | Study of Vitamin D in Untreated Metastatic Colorectal Cancer | ||
| NCT02653755 | The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer | ||
| NCT00809250 | Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation | ||
| NCT04717050 | Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity | ||
| NCT03447886 | Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds | ||
| NCT00670982 | Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer | ||
| NCT00642759 | Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer | ||
| NCT02823262 | A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older | ||
| NCT05774886 | Implantable Microdevice for TNBC - Pilot Study | ||
| NCT02022982 | PALBOCICLIB + PD-0325901 for NSCLC & Solid Tumors | ||
| NCT06854003 | BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma | ||
| NCT06623097 | Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study | ||
| NCT00146562 | Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer | ||
| NCT02943642 | Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides | ||
| NCT00954720 | Observational Study of Iron Overload in Stem Cell Transplantation | ||
| NCT00153920 | Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma | ||
| NCT04045470 | A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma | ||
| NCT02658396 | GO-203-2C + Bortezomib For Relapsed Or Refractory MM | ||
| NCT00782626 | Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas | ||
| NCT03225716 | A Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemia | ||
| NCT06298734 | High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial | ||
| NCT04166487 | Plasma-Adapted First-Line Pembro In NSCLC | ||
| NCT06805617 | A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers | ||
| NCT01191060 | Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 Years |
